SCHEMBL30367145

SCHEMBL30367145

O=CCN1CCN(CCOc2ccc(Oc3c(-c4ccc(Br)cc4)sc4cc(O)ccc34)cc2)CC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 18/20 0.79
ESR2 Q92731 16/20 0.79
MEN1 O00255 2/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
TP53 P04637 2/20 0.54
CYP3A4 P08684 2/20 0.54
MAPT P10636 2/20 0.54
ALOX15 P16050 2/20 0.54
KMT2A Q03164 2/20 0.54
HSD17B10 Q99714 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
PLD2 O14939 1/20 0.54
KDM1A O60341 1/20 0.54
NR1I2 O75469 1/20 0.54
USP2 O75604 1/20 0.54
C5 P01031 1/20 0.54
FYN P06241 1/20 0.54
PGR P06401 1/20 0.54
ADRA2A P08913 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20423180 1.00 ESR1 (0.79) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL17154284 0.88 ESR1 (1.00) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20442773 0.88 ESR1 (0.79) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20425292 0.87 ESR1 (0.78) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20423351 0.87 ESR1 (0.83) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL30367306 0.87 ESR1 (0.83) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20442772 0.86 ESR1 (0.75) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL30367496 0.85 ESR1 (0.77) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20423397 0.85 ESR1 (0.77) ESR1ESR2MEN1ALDH1A1LMNA
SCHEMBL20425300 0.85 ESR1 (0.74) ESR1ESR2MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313547-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS INC (US) 2025-10-09 US disclosed
CN-110612294-B Human cerebulin ligands and bifunctional compounds comprising same 阿尔维纳斯运营股份有限公司 2024-01-16 CN disclosed
CN-115974840-A Human cereblon ligand and bifunctional compound comprising same 阿尔维纳斯运营股份有限公司 2023-04-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313547-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME CRBN, CBL, MDM2 ESR1 2847/4885ESR2 1400/4885MEN1 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.